Repligen Corp

RGENNASDAQ • USD
161.76 USD
↘ 1.03 (0.63%)🟢LIVE (AS OF 10:58 AM EST)
🟢Market: OPEN

Repligen Corp (RGEN) trades at $161.76 per share. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, RGEN is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 16, 2026.

Open?$162.78
High?$166.00
Low?$160.78
Prev. Close?$162.78
Volume?84.7K
Avg. Volume?1.3M
VWAP?$162.73
Rel. Volume?0.07x
Bid / Ask
Bid?$161.35 × 100
Ask?$162.67 × 100
Spread?$1.32
Midpoint?$162.01
Valuation & Ratios
Market Cap?10.4B
Shares Out?63.9M
Float?56.0M
Float %?99.2%
P/E Ratio?N/A
P/B Ratio?4.97
EPS?-$0.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Employees
2.0K
Market Cap
10.4B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1986-04-29
Address
41 SEYON STREET
WALTHAM, MA 02453
Phone: (781) 449-9560
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
8
Short Sent.?
60
Piotroski F-Score?3/9Weak
Altman Z-Score?8.44Safe
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.61%High
Short Interest?7.1M
Days to Cover?4.9
Free Float56.0M
Avg Daily Volume1.4M
Settlement Date2026-10-30
Financial Health
Current Ratio?9.88Strong
Quick Ratio?8.43Strong
Cash Ratio?5.78Strong
Debt/Equity?0.27Low
ValuationRICHLY VALUEDvs 7 peers + S&P 500
Score
40/100
P/E?
N/A▾
P/B?
Peers
50
S&P
37
4.97FAIR▾
P/S?
Peers
25
S&P
3
12.92HIGH▾
P/FCF?
Peers
25
S&P
3
97.5PRICEY▾
EV/EBITDA?
Peers
25
S&P
3
70.0HIGH▾
EV/Sales?
Peers
25
S&P
7
12.70HIGH▾
Returns & Efficiency
ROE?
Peers
13
S&P
15
-0.6%WEAK▾
ROA?
Peers
13
S&P
6
-0.4%WEAK▾
Cash Flow & Enterprise
FCF?$106.7M
Enterprise Value?$10.2B
Fundamentals ratios updated end of day